In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardiac product developers see hearty revenues

This article was originally published in Clinica

Executive Summary

Sales growth in Angeion's line of cardiorespiratory diagnostic products and its New Leaf Health and Fitness franchise has led to an overall 10% increase in second-quarter revenues for 2004. During this period, the St Paul, Minnesota company began shipment of its new CPX Ultima gas exchange metabolic cart system. New losses recorded for both second-quarter and first-half periods were due to charges relating to the discontinuation of its implantable cardioverter defibrillator (ICD) product line at the end of 1999.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059155

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel